Literature DB >> 1848067

Immunological relationships between parainfluenza virus type 4 and other paramyxoviruses studied by use of monoclonal antibodies.

H Komada1, E Klippmark, C Orvell, R E Randall, Y Ito, E Norrby.   

Abstract

These results demonstrated that cross-reactions between mumps virus, PIV-2, PIV-4, and SV5 involve both internal components and surface glycoproteins and that these viruses form a separate group within the paramyxovirus genus.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1848067     DOI： 10.1007/bf01319249

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  18 in total

1.  ANTIGENIC VARIATION AMONG NEWLY ISOLATED STRAINS OF PARAINFLUENZA TYPE 4 VIRUS.

Authors:  J CANCHOLA; A J VARGOSKO; H W KIM; R H PARROTT; E CHRISTMAS; B JEFFRIES; R M CHANOCK
Journal:  Am J Hyg       Date:  1964-05

2.  Studies of a new human hemadsorption virus. I. Isolation, properties and characterization.

Authors:  K M JOHNSON; R M CHANOCK; M K COOK; R J HUEBNER
Journal:  Am J Hyg       Date:  1960-01

3.  Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates.

Authors:  R E Randall; D F Young; K K Goswami; W C Russell
Journal:  J Gen Virol       Date:  1987-11       Impact factor: 3.891

4.  Monoclonal antibodies against the glycoproteins of mumps virus: fusion inhibition by anti-HN monoclonal antibody.

Authors:  M Tsurudome; A Yamada; M Hishiyama; Y Ito
Journal:  J Gen Virol       Date:  1986-10       Impact factor: 3.891

5.  The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus.

Authors:  C Orvell; M Grandien
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

6.  Isolation and characterization of monoclonal antibodies to human parainfluenza virus type 4 and their use in revealing antigenic relation between subtypes 4A and 4B.

Authors:  H Komada; M Tsurudome; M Ueda; M Nishio; H Bando; Y Ito
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

7.  Comparison between parainfluenza virus type 2 and simian virus 5: monoclonal antibodies reveal major antigenic differences.

Authors:  R E Randall; D F Young
Journal:  J Gen Virol       Date:  1988-08       Impact factor: 3.891

8.  Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies.

Authors:  M Tsurudome; M Nishio; H Komada; H Bando; Y Ito
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

9.  Immunological relationships between homologous structural polypeptides of measles and canine distemper virus.

Authors:  C Orvell; E Norrby
Journal:  J Gen Virol       Date:  1980-10       Impact factor: 3.891

10.  The reactions of monoclonal antibodies with structural proteins of mumps virus.

Authors:  C Orvell
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422
View more
  6 in total

Review 1.  Methods for subtyping and molecular comparison of human viral genomes.

Authors:  M Arens
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge.

Authors:  S Mark Tompkins; Yuan Lin; George P Leser; Kari A Kramer; Debra L Haas; Elizabeth W Howerth; Jie Xu; Mary J Kennett; Russell K Durbin; Joan E Durbin; Ralph Tripp; Robert A Lamb; Biao He
Journal:  Virology       Date:  2007-01-23       Impact factor: 3.616

3.  Multiple amino acid substitutions in the HN protein of the paramyxovirus, SV5, are selected for in monoclonal antibody resistant mutants.

Authors:  D U Baty; R E Randall
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Differential durability of immune responses to measles and mumps following MMR vaccination.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Antonia Thomas; Beth R Larrabee; Steven Rubin; Gregory A Poland
Journal:  Vaccine       Date:  2019-02-20       Impact factor: 3.641

5.  Evaluating a parainfluenza virus 5-based vaccine in a host with pre-existing immunity against parainfluenza virus 5.

Authors:  Zhenhai Chen; Pei Xu; Gregory W Salyards; Stephen B Harvey; Balazs Rada; Zhen F Fu; Biao He
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

Review 6.  The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid.

Authors:  Maja Šantak; Zrinka Matić
Journal:  Viruses       Date:  2022-03-03       Impact factor: 5.048
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.